The biotech industry is gearing up for JPM Week 2024 in San Francisco, with high expectations for mergers and acquisitions (M&A) following a successful end to 2023. Companies like Bristol Myers Squibb, Moderna, Novartis, and Sarepta Therapeutics are expected to make significant presentations. Updates from Vertex Pharmaceuticals and advancements in artificial intelligence (AI) are also anticipated. Historically, the biotech stocks index has shown mixed results during JPM Week, with the potential for volatility in an election year like 2024. STAT will be covering the event with video content and providing updates across various platforms.
Source link
Sky high deal expectations at JPM 2024
